Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)
Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API manufacturer). (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 16, 2019 Category: Food Science Source Type: news
Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25mg, 50mg, And 100mg Due to The Detection of Trace Amounts Of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in The Active Pharmaceutical Ingredient (API)
Earth City, MO, Legacy Pharmaceutical Packaging, LLC is recalling 40 repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg to the consumer level. This recall was prompted due to Camber Pharmaceuticals, Inc. issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API manufacturer). (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 15, 2019 Category: Food Science Source Type: news
FDA Updates Sartan Recalls; Finds New Impurity FDA Updates Sartan Recalls; Finds New Impurity
Two companies recall losartan products owing to the presence of N-nitroso-N-methyl-4-aminobutyric acid (NMBA), the third type of nitrosamine impurity detected in angiotensin II receptor blockers.News Alerts (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 6, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
Blood pressure medication recall expands again to include losartan
A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan. The recall is due to an "impurity" that is classified as a potential human carcinogen. (Source: CNN.com - Health)
Source: CNN.com - Health - March 4, 2019 Category: Consumer Health News Source Type: news
losartan and hydrochlorothiazide (Hyzaar)
Title: losartan and hydrochlorothiazide (Hyzaar)Category: MedicationsCreated: 3/12/2000 12:00:00 AMLast Editorial Review: 3/4/2019 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - March 4, 2019 Category: Cardiology Source Type: news
Blood pressure drug recall expands over third possible carcinogen
Drug companies expanded a recall of Losartan lots after detecting a third potentially cancer-causing impurity in blood pressure medication. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 2, 2019 Category: Consumer Health News Source Type: news
Blood Pressure Medication Recall Expands Again To Include Losartan
(CNN) — A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan. The recall is due to an “impurity” that is classified as a potential human carcinogen.
The impurity, N-Nitroso-N-methyl-4-aminobutyric acid or NMBA, is also classified as a known animal carcinogen, the US Food And Drug Administration noted in a news release about the recall Friday.
Camber Pharmaceuticals Inc. voluntarily recalled 87 lots of losartan tablets in the United States on Thursday. The recalled tablets, made by Hetero Labs Ltd. In India and distributed by...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 1, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News FDA losartan Valsartan Source Type: news
Updated: Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium /Hydrochlorothiazide Tablets, USP
Torrent Pharmaceuticals Limited is voluntarily recalling 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/ hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 1, 2019 Category: Food Science Source Type: news
Another Day, Another ARB, Another Contaminant
(MedPage Today) -- Losartan lots from Indian drugmaker recalled for novel carcinogen (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 1, 2019 Category: American Health Source Type: news
Blood pressure drug Losartan recalled
Camber Pharmaceuticals is voluntarily recalling 87 lots of the blood pressure drug Losartan due to traces of a potential carcinogen. The affected products come in 25, 50 and 100 milligram doses. The company urges consumers to consult their doctor before stopping treatment. Since 2018, there have been at least 19 recalls of versions of the drug over cancer fears. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 1, 2019 Category: Consumer Health News Source Type: news
FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall
FDA provides update on ongoing investigation into ARB drugs; new losartan recall announced (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 1, 2019 Category: American Health Source Type: news
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)
Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. This recall was prompted due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer). (Source: Food and Drug Administration)
Source: Food and Drug Administration - March 1, 2019 Category: Food Science Source Type: news
Another Drug Company Recalls Tainted Losartan Another Drug Company Recalls Tainted Losartan
Macleods Pharmaceuticals Limited is voluntarily recalling one lot of losartan potassium and hydrochlorothiazide combination tablets owing to the presence of a probable carcinogen.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 27, 2019 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news
Macleods Pharmaceuticals Limited Issues Voluntary Nationwide Consumer Level Recall of One Lot (BLM 715A) of Losartan Potassium/Hydrochlorothiazide Combination Tablets 100mg/25mg Due to detection of NDEA (N-Nitrosodiethylamine) Impurity
Macleods Pharmaceuticals Limited is voluntarily recalling one lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer level due to the detection of trace amounts of an unexpected impurity (NDEA) found in finished product manufactured with active pharmaceutical ingredient made by Hetero Labs Limited. (Source: Food and Drug Administration)
Source: Food and Drug Administration - February 25, 2019 Category: Food Science Source Type: news
Commonly-prescribed blood-pressure drug may combat PTSD
A study by the University of Electronic Science and Technology of China found the hypertension drug losartan - also known by its brand name Cozaar - helps people sweat less when faced with a fear. (Source: the Mail online | Health)
Source: the Mail online | Health - February 19, 2019 Category: Consumer Health News Source Type: news
